{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:38:08Z","timestamp":1776872288213,"version":"3.51.2"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 HD057877"],"award-info":[{"award-number":["P01 HD057877"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 HD098580"],"award-info":[{"award-number":["P50 HD098580"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Uterine leiomyomas (fibroids) are common benign tumors in women. The tryptophan metabolism through the kynurenine pathway plays important roles in tumorigenesis in general. Leiomyomas expressing mutated mediator complex subunit 12 (mut-MED12) were reported to contain significantly decreased tryptophan levels; the underlying mechanism and the role of the tryptophan metabolism-kynurenine pathway in leiomyoma tumorigenesis, however, remain unknown. We here assessed the expression and regulation of the key enzymes that metabolize tryptophan. Among these, the tissue mRNA levels of tryptophan 2,3-dioxygenase (TDO2), the rate limiting enzyme of tryptophan metabolism through the kynurenine pathway, was 36-fold higher in mut-MED12 compared to adjacent myometrium (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001), and 14-fold higher compared to wild type (wt)-MED12 leiomyoma (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). The mRNA levels of other tryptophan metabolizing enzymes, IDO1 and IDO2, were low and not significantly different, suggesting that TDO2 is the key enzyme responsible for reduced tryptophan levels in mut-MED12 leiomyoma. R5020 and medroxyprogesterone acetate (MPA), two progesterone agonists, regulated TDO2 gene expression in primary myometrial and leiomyoma cells expressing wt-MED12; however, this effect was absent or blunted in leiomyoma cells expressing G44D mut-MED12. These data suggest that MED12 mutation may alter progesterone-mediated TDO2 expression in leiomyoma, leading to lower levels of tryptophan in mut-MED12 leiomyoma. This highlights that fibroids can vary widely in their response to progesterone as a result of mutation status and provides some insight for understanding the effect of tryptophan-kynurenine pathway on leiomyoma tumorigenesis and identifying targeted interventions for fibroids based on their distinct molecular signatures.<\/jats:p>","DOI":"10.1007\/s43032-022-00852-y","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T20:05:04Z","timestamp":1642795504000},"page":"743-749","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Tryptophan 2,3-Dioxygenase-2 in Uterine Leiomyoma: Dysregulation by MED12 Mutation Status"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7401-8682","authenticated-orcid":false,"given":"Anne P.","family":"Hutchinson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilona","family":"Neale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"V","given":"John S.","family":"Coon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacy A.","family":"Kujawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serdar E.","family":"Bulun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"issue":"1","key":"852_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.fertnstert.2010.08.049","volume":"95","author":"WH Catherino","year":"2011","unstructured":"Catherino WH, Parrott E, Segars J. Proceedings from theNational Institute of Child Health and Human Development conference on the Uterine Fibroid Research Update Workshop. Fertil Steril. 2011;95(1):9\u201312.","journal-title":"Fertil Steril"},{"key":"852_CR2","doi-asserted-by":"crossref","unstructured":"Cardozo, E.R., et al. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol, 2012. 206(3): p. 211 e1\u20139.","DOI":"10.1016\/j.ajog.2011.12.002"},{"issue":"10","key":"852_CR3","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1093\/hmg\/dds051","volume":"21","author":"JC Hodge","year":"2012","unstructured":"Hodge JC, et al. Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity. Hum Mol Genet. 2012;21(10):2312\u201329.","journal-title":"Hum Mol Genet"},{"issue":"6053","key":"852_CR4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1126\/science.1208930","volume":"334","author":"N Makinen","year":"2011","unstructured":"Makinen N, et al. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science. 2011;334(6053):252\u20135.","journal-title":"Science"},{"issue":"3","key":"852_CR5","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.celrep.2014.03.047","volume":"7","author":"M Turunen","year":"2014","unstructured":"Turunen M, et al. Uterine leiomyoma-linked MED12 mutations disrupt mediator-associated CDK activity. Cell Rep. 2014;7(3):654\u201360.","journal-title":"Cell Rep"},{"issue":"12","key":"852_CR6","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1038\/bjc.2017.361","volume":"117","author":"HR Heinonen","year":"2017","unstructured":"Heinonen HR, et al. Global metabolomic profiling of uterine leiomyomas. Br J Cancer. 2017;117(12):1855\u201364.","journal-title":"Br J Cancer"},{"key":"852_CR7","doi-asserted-by":"publisher","first-page":"117864691769193","DOI":"10.1177\/1178646917691938","volume":"10","author":"AA Badawy","year":"2017","unstructured":"Badawy AA. Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects. Int J Tryptophan Res. 2017;10:1178646917691938.","journal-title":"Int J Tryptophan Res"},{"key":"852_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.mrrev.2018.03.001","volume":"776","author":"FA Boros","year":"2018","unstructured":"Boros FA, Bohar Z, Vecsei L. Genetic alterations affecting the genes encoding the enzymes of the kynurenine pathway and their association with human diseases. Mutat Res. 2018;776:32\u201345.","journal-title":"Mutat Res"},{"issue":"6","key":"852_CR9","doi-asserted-by":"publisher","first-page":"6506","DOI":"10.18632\/oncotarget.6467","volume":"7","author":"B Heng","year":"2016","unstructured":"Heng B, et al. Understanding the role of the kynurenine pathway in human breast cancer immunobiology. Oncotarget. 2016;7(6):6506\u201320.","journal-title":"Oncotarget"},{"issue":"5","key":"852_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","volume":"18","author":"M Platten","year":"2019","unstructured":"Platten M, et al. Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat Rev Drug Discov. 2019;18(5):379\u2013401.","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"852_CR11","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1210\/en.2009-1225","volume":"151","author":"H Ishikawa","year":"2010","unstructured":"Ishikawa H, et al. Progesterone is essential for maintenance and growth of uterine leiomyoma. Endocrinology. 2010;151(6):2433\u201342.","journal-title":"Endocrinology"},{"key":"852_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.omto.2020.03.013","volume":"17","author":"Q Liu","year":"2020","unstructured":"Liu Q, et al. Comprehensive analysis of the expression and prognosis for TDO2 in breast cancer. Mol Ther Oncolytics. 2020;17:153\u201368.","journal-title":"Mol Ther Oncolytics"},{"issue":"1","key":"852_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1530\/JOE-13-0429","volume":"220","author":"DD Li","year":"2014","unstructured":"Li DD, et al. Differential expression and regulation of Tdo2 during mouse decidualization. J Endocrinol. 2014;220(1):73\u201383.","journal-title":"J Endocrinol"},{"issue":"3","key":"852_CR14","first-page":"1716","volume":"130","author":"MJ Rossi","year":"1992","unstructured":"Rossi MJ, Chegini N, Masterson BJ. Presence of epidermal growth factor, platelet-derived growth factor, and their receptors in human myometrial tissue and smooth muscle cells: their action in smooth muscle cells in vitro. Endocrinology. 1992;130(3):1716\u201327.","journal-title":"Endocrinology"},{"issue":"1","key":"852_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1056\/NEJMoa1302736","volume":"369","author":"M Mehine","year":"2013","unstructured":"Mehine M, et al. Characterization of uterine leiomyomas by whole-genome sequencing. N Engl J Med. 2013;369(1):43\u201353.","journal-title":"N Engl J Med"},{"issue":"21","key":"852_CR16","doi-asserted-by":"publisher","first-page":"34762","DOI":"10.18632\/oncotarget.16711","volume":"8","author":"J Bloch","year":"2017","unstructured":"Bloch J, et al. Factors affecting the loss of MED12-mutated leiomyoma cells during in vitro growth. Oncotarget. 2017;8(21):34762\u201372.","journal-title":"Oncotarget"},{"issue":"8","key":"852_CR17","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/modpathol.2013.243","volume":"27","author":"E Bertsch","year":"2014","unstructured":"Bertsch E, et al. MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma. Mod Pathol. 2014;27(8):1144\u201353.","journal-title":"Mod Pathol"},{"issue":"5","key":"852_CR18","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.cell.2012.11.003","volume":"151","author":"X Guo","year":"2012","unstructured":"Guo X, Wang XF. A mediator lost in the war on cancer. Cell. 2012;151(5):927\u20139.","journal-title":"Cell"},{"issue":"7","key":"852_CR19","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/ijc.27424","volume":"131","author":"DN Markowski","year":"2012","unstructured":"Markowski DN, et al. MED12 mutations in uterine fibroids\u2013their relationship to cytogenetic subgroups. Int J Cancer. 2012;131(7):1528\u201336.","journal-title":"Int J Cancer"},{"issue":"10","key":"852_CR20","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/molehr\/gau055","volume":"20","author":"S Di Tommaso","year":"2014","unstructured":"Di Tommaso S, et al. Missense mutations in exon 2 of the MED12 gene are involved in IGF-2 overexpression in uterine leiomyoma. Mol Hum Reprod. 2014;20(10):1009\u201315.","journal-title":"Mol Hum Reprod"},{"issue":"3","key":"852_CR21","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s43032-019-00084-7","volume":"27","author":"A El Andaloussi","year":"2020","unstructured":"El Andaloussi A, et al. Introduction of somatic mutation in MED12 induces Wnt4\/beta-catenin and disrupts autophagy in human uterine myometrial cell. Reprod Sci. 2020;27(3):823\u201332.","journal-title":"Reprod Sci"},{"issue":"5","key":"852_CR22","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1073\/pnas.1518752113","volume":"113","author":"M Mehine","year":"2016","unstructured":"Mehine M, et al. Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers. Proc Natl Acad Sci U S A. 2016;113(5):1315\u201320.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"852_CR23","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1002\/jcb.25499","volume":"117","author":"B Banaganapalli","year":"2016","unstructured":"Banaganapalli B, et al. A computational protein phenotype prediction approach to analyze the deleterious mutations of human MED12 gene. J Cell Biochem. 2016;117(9):2023\u201335.","journal-title":"J Cell Biochem"},{"issue":"13","key":"852_CR24","doi-asserted-by":"publisher","first-page":"4870","DOI":"10.1074\/jbc.RA118.001725","volume":"293","author":"MJ Park","year":"2018","unstructured":"Park MJ, et al. Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8\/19. J Biol Chem. 2018;293(13):4870\u201382.","journal-title":"J Biol Chem"},{"issue":"15","key":"852_CR25","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1038\/s41388-018-0612-6","volume":"38","author":"S Liu","year":"2019","unstructured":"Liu S, et al. Progesterone receptor integrates the effects of mutated MED12 and altered DNA methylation to stimulate RANKL expression and stem cell proliferation in uterine leiomyoma. Oncogene. 2019;38(15):2722\u201335.","journal-title":"Oncogene"},{"issue":"5","key":"852_CR26","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1002\/j.1460-2075.1990.tb08280.x","volume":"9","author":"P Kastner","year":"1990","unstructured":"Kastner P, et al. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 1990;9(5):1603\u201314.","journal-title":"EMBO J"},{"issue":"10","key":"852_CR27","first-page":"1244","volume":"7","author":"E Vegeto","year":"1993","unstructured":"Vegeto E, et al. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol Endocrinol. 1993;7(10):1244\u201355.","journal-title":"Mol Endocrinol"},{"issue":"12","key":"852_CR28","first-page":"8356","volume":"14","author":"DX Wen","year":"1994","unstructured":"Wen DX, et al. The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Mol Cell Biol. 1994;14(12):8356\u201364.","journal-title":"Mol Cell Biol"},{"key":"852_CR29","doi-asserted-by":"crossref","unstructured":"Tanos T, et al. Progesterone\/RANKL is a major regulatory axis in the human breast. Sci Transl Med, 2013. 5(182): p. 182ra55.","DOI":"10.1126\/scitranslmed.3005654"},{"issue":"5","key":"852_CR30","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1210\/jc.2017-01585","volume":"103","author":"DE Ikhena","year":"2018","unstructured":"Ikhena DE, et al. RANKL\/RANK Pathway and Its Inhibitor RANK-Fc in Uterine Leiomyoma Growth. J Clin Endocrinol Metab. 2018;103(5):1842\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"852_CR31","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/j.1460-2075.1987.tb04800.x","volume":"6","author":"U Danesch","year":"1987","unstructured":"Danesch U, et al. Glucocorticoid induction of the rat tryptophan oxygenase gene is mediated by two widely separated glucocorticoid-responsive elements. EMBO J. 1987;6(3):625\u201330.","journal-title":"EMBO J"},{"issue":"2","key":"852_CR32","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0021-9258(19)75845-1","volume":"262","author":"T Nakamura","year":"1987","unstructured":"Nakamura T, et al. Multihormonal regulation of transcription of the tryptophan 2,3-dioxygenase gene in primary cultures of adult rat hepatocytes with special reference to the presence of a transcriptional protein mediating the action of glucocorticoids. J Biol Chem. 1987;262(2):727\u201333.","journal-title":"J Biol Chem"},{"issue":"1","key":"852_CR33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/glia.22734","volume":"63","author":"M Ott","year":"2015","unstructured":"Ott M, et al. Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway. Glia. 2015;63(1):78\u201390.","journal-title":"Glia"},{"issue":"4","key":"852_CR34","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.fertnstert.2021.05.081","volume":"116","author":"TD Chuang","year":"2021","unstructured":"Chuang TD, et al. Tryptophan catabolism is dysregulated in leiomyomas. Fertil Steril. 2021;116(4):1160\u201371.","journal-title":"Fertil Steril"},{"issue":"2","key":"852_CR35","first-page":"513","volume":"76","author":"AA Murphy","year":"1993","unstructured":"Murphy AA, et al. Regression of uterine leiomyomata in response to the antiprogesterone RU 486. J Clin Endocrinol Metab. 1993;76(2):513\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"852_CR36","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1093\/humrep\/dem026","volume":"22","author":"AR Williams","year":"2007","unstructured":"Williams AR, et al. The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata. Hum Reprod. 2007;22(6):1696\u2013704.","journal-title":"Hum Reprod"},{"issue":"5","key":"852_CR37","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1056\/NEJMoa1103180","volume":"366","author":"J Donnez","year":"2012","unstructured":"Donnez J, et al. Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl J Med. 2012;366(5):421\u201332.","journal-title":"N Engl J Med"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-022-00852-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-022-00852-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-022-00852-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T09:07:38Z","timestamp":1645520858000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-022-00852-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["852"],"URL":"https:\/\/doi.org\/10.1007\/s43032-022-00852-y","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]},"assertion":[{"value":"10 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}